Stocks News

LAST PRICE
122.0000
TODAY'S CHANGE (%)
Trending Down-4.5100 (-3.5649%)

Bid / Lots
117.8300/ 1
Ask / Lots
130.5000/ 1
Open / Previous Close
127.3400 / 126.5100
Day Range
Low 120.7300
High 127.3400
52 Week Range
Low 90.1300
High 161.0000
Volume
611,057
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- European Equities Traded in the US as American Depositary Rise in Monday Trading, from 6 hours ago by MT Newswires
  6 hours ago by MT Newswires
  Companies Mentioned: NTZ, NVO, TEF, SQNS, GRFS, AMRN, OPRA, AKTX, MREO, SLN, EVAX, BP, TCBP, ASND, ADAP, BDRX
  11:21 AM EST, 11/18/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts opened the week higher late Monday morning, rising 0.41% to 1,307.69 on the S&P Europe Select ADR Index. From continental Europe, the gaine...
Nov 15, 2024
- DJ Ascendis Pharma Is Maintained at Buy by TD Cowen, from 1:48PM ET on Friday Nov 15, 2024 by Dow Jones
  1:48PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: ASND
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ASND/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 15, 2024 13:48 ET (18:48 GMT)
- DJ Ascendis Pharma Price Target Maintained With a $181.00/Share by Wedbush, from 1:11PM ET on Friday Nov 15, 2024 by Dow Jones
  1:11PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: ASND
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ASND/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 15, 2024 13:11 ET (18:11 GMT)
- European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week, from 11:09AM ET on Friday Nov 15, 2024 by MT Newswires
  11:09AM ET on Friday Nov 15, 2024 by MT Newswires
  Companies Mentioned: BBVA, LYG, PUK, ARGX, AKTX, MREO, BCYC, BNTX, EVAX, BTI, TCBP, DBVT, ASND, CLLS, SAN, BDRX
  11:09 AM EST, 11/15/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were moving lower late Friday morning, declining 0.85% to 1,302.64 on the S&P Europe Select ADR Index, which is down about 2.8% for the wee...
- DJ Ascendis Pharma Is Maintained at Outperform by Oppenheimer, from 11:03AM ET on Friday Nov 15, 2024 by Dow Jones
  11:03AM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: ASND
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ASND/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 15, 2024 11:03 ET (16:03 GMT)

Today
- DJ Blueprint Medicines Price Target Maintained With a $125.00/Share by JMP Securities, from 5 hours ago by Dow Jones
  5 hours ago by Dow Jones
  Companies Mentioned: BPMC
Nov 15, 2024
- DJ Blueprint Medicines Price Target Maintained With a $135.00/Share by HC Wainwright & Co., from 6:42AM ET on Friday Nov 15, 2024 by Dow Jones
  6:42AM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: BPMC
- DJ Blueprint Medicines Price Target Maintained With a $135.00/Share by Needham, from 5:17AM ET on Friday Nov 15, 2024 by Dow Jones
  5:17AM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: BPMC
- Intra-Cellular Therapies Insider Sold Shares Worth $3,692,100, According to a Recent SEC Filing, from 3:51AM ET on Friday Nov 15, 2024 by MT Newswires
  3:51AM ET on Friday Nov 15, 2024 by MT Newswires
  Companies Mentioned: ITCI
Nov 14, 2024
- DJ Blueprint Medicines Initiated at Overweight by JP Morgan, from 7:48AM ET on Thursday Nov 14, 2024 by Dow Jones
  7:48AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: BPMC
- JPMorgan Initiates Blueprint Medicines at Overweight With $126 Price Target, from 7:40AM ET on Thursday Nov 14, 2024 by MT Newswires
  7:40AM ET on Thursday Nov 14, 2024 by MT Newswires
  Companies Mentioned: BPMC
Nov 13, 2024
- DJ Legend Biotech Price Target Maintained With a $73.00/Share by HC Wainwright & Co., from 9:20AM ET on Wednesday Nov 13, 2024 by Dow Jones
  9:20AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: LEGN
Nov 12, 2024
- DJ Tempus AI Price Target Raised to $70.00/Share From $40.00 by Piper Sandler, from 11:19AM ET on Tuesday Nov 12, 2024 by Dow Jones
  11:19AM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: TEM
- Tempus Molecular Profiling Integration Now Available Through Flatiron's OncoEMR(R), from 8:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
  8:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: TEM
- Legend Biotech Q3 Loss Widens, Revenue Rises, from 7:45AM ET on Tuesday Nov 12, 2024 by MT Newswires
  7:45AM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: LEGN

Ascendis Pharma A/S
NASDAQ:ASNDUnited States

Search Criteria

Today

European Equities Traded in the US as American Depositary Rise in Monday Trading, from 6 hours ago by MT Newswires

Nov 15, 2024

DJ Ascendis Pharma Is Maintained at Buy by TD Cowen, from 1:48PM ET on Friday Nov 15, 2024 by Dow Jones

DJ Ascendis Pharma Price Target Maintained With a $181.00/Share by Wedbush, from 1:11PM ET on Friday Nov 15, 2024 by Dow Jones

European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week, from 11:09AM ET on Friday Nov 15, 2024 by MT Newswires

DJ Ascendis Pharma Is Maintained at Outperform by Oppenheimer, from 11:03AM ET on Friday Nov 15, 2024 by Dow Jones

Peers Headlines

Today

DJ Blueprint Medicines Price Target Maintained With a $125.00/Share by JMP Securities, from 5 hours ago by Dow Jones

Nov 15, 2024

DJ Blueprint Medicines Price Target Maintained With a $135.00/Share by HC Wainwright & Co., from 6:42AM ET on Friday Nov 15, 2024 by Dow Jones

DJ Blueprint Medicines Price Target Maintained With a $135.00/Share by Needham, from 5:17AM ET on Friday Nov 15, 2024 by Dow Jones

Intra-Cellular Therapies Insider Sold Shares Worth $3,692,100, According to a Recent SEC Filing, from 3:51AM ET on Friday Nov 15, 2024 by MT Newswires

Nov 14, 2024

DJ Blueprint Medicines Initiated at Overweight by JP Morgan, from 7:48AM ET on Thursday Nov 14, 2024 by Dow Jones

JPMorgan Initiates Blueprint Medicines at Overweight With $126 Price Target, from 7:40AM ET on Thursday Nov 14, 2024 by MT Newswires

Nov 13, 2024

DJ Legend Biotech Price Target Maintained With a $73.00/Share by HC Wainwright & Co., from 9:20AM ET on Wednesday Nov 13, 2024 by Dow Jones

Nov 12, 2024

DJ Tempus AI Price Target Raised to $70.00/Share From $40.00 by Piper Sandler, from 11:19AM ET on Tuesday Nov 12, 2024 by Dow Jones

Tempus Molecular Profiling Integration Now Available Through Flatiron's OncoEMR(R), from 8:30AM ET on Tuesday Nov 12, 2024 by Dow Jones

Legend Biotech Q3 Loss Widens, Revenue Rises, from 7:45AM ET on Tuesday Nov 12, 2024 by MT Newswires